Article
Pattern and prevalence of rifampicin and isoniazid-resistant tuberculosis using genotype MTBDRplus assay in Ethiopia.
Microbiology spectrum - 7 Apr 2026
Getahun Muluwork, Ameni Gobena, Mollalign Hilina, Diriba Getu, Beyene Dereje
Abstract excerpt
Resistance-conferring mutations in Mycobacterium tuberculosis (Mtb) are primary drivers of therapeutic challenges. However, comprehensive resistance mutation profiles are lacking in low- and middle-income countries. This study assesses the patterns and prevalence of isoniazid (INH) or multidrug/rifampicin-resistant (MDR/RR) tuberculosis (TB) mutations. We used stored Mtb isolates obtained from smear-positive TB...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
